SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-014612
Filing Date
2016-03-14
Accepted
2016-03-11 17:35:29
Documents
84
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K snss-10k_20151231.htm 10-K 3676305
2 EX-10.45 snss-ex1045_501.htm EX-10.45 45505
3 EX-23.1 snss-ex231_588.htm EX-23.1 21385
4 EX-31.1 snss-ex311_376.htm EX-31.1 16568
5 EX-31.2 snss-ex312_375.htm EX-31.2 17002
6 EX-32.1 snss-ex321_377.htm EX-32.1 8794
7 GRAPHIC g2016031122261069611571.jpg GRAPHIC 26508
8 GRAPHIC g2016031122260099911570.jpg GRAPHIC 95115
  Complete submission text file 0001564590-16-014612.txt   11177217

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT snss-20151231.xml EX-101.INS 2334175
10 XBRL TAXONOMY EXTENSION SCHEMA snss-20151231.xsd EX-101.SCH 73955
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20151231_cal.xml EX-101.CAL 56286
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20151231_def.xml EX-101.DEF 198715
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20151231_lab.xml EX-101.LAB 518461
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20151231_pre.xml EX-101.PRE 392264
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 161501931
SIC: 2834 Pharmaceutical Preparations